Status:
COMPLETED
Subconjunctival Injection of Triamcinolone Acetonide and Limited Peritomy During Pterygium Excision
Lead Sponsor:
Assiut University
Conditions:
Pterygium
Eligibility:
All Genders
Phase:
NA
Brief Summary
Pterygium is characterized by encroachment of a fleshy fibrovascular tissue from the bulbar conjunctiva on to the cornea. Although previously thought to be a solely degenerative disease, a new evidence...
Detailed Description
One of the factors that may have a role in the outcome of pterygium surgery is postoperative conjunctival inflammation , treatment of which has been demonstrated to improve the final outcome . It has b...
Eligibility Criteria
Inclusion
- primary pterygium.
Exclusion
- preexisting glaucoma .
- patient with family history of glaucoma
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03377348
Start Date
December 1 2017
End Date
December 1 2019
Last Update
February 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alaa M. Abdelhafez
Asyut, Egypt